Guidance for DepoMed Inc. (ASRT)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| Q4 2019 | N/A | N/A | N/A | $2.00M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2017 | N/A | N/A | $410.00M – 430.00M | $473.00M |  Lowered |
Details |
| 2017 | N/A | N/A | $395.00M – 410.00M | $416.30M | = Maintained | Details |
| 2017 | N/A | N/A | $375.00M – 380.00M | $393.60M | Lowered |
Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2015 | N/A | N/A | $320.00M – 340.00M | N/A |  Raised |
Details |
| 2015 | N/A | N/A | $310.00M – 335.00M | $305.02M | Raised |
Details |
| 2014 | $0.00 – $0.16 | N/A | N/A | N/A | = Maintained | Details |
| 2014 | $0.06 – $0.14 | $0.47 | $232.00M – 242.00M | $231.47M | Raised |
Details |
| 2013 | N/A | N/A | $125.00M – 135.00M | $136.80M | = Maintained | Details |
| 2013 | N/A | N/A | $125.00M – 130.00M | $130.22M | = Maintained | Details |
